https://www.marketscreener.com/quote/stock/ARCH-BIOPARTNERS-INC-120793034/news/Arch-Biopartners-Adds-Three-New-Clinical-Sites-into-the-Phase-Ii-Trial-for-Lsalt-Peptide-Targeting-C-46339687/?utm_source=telegram&utm_medium=social&utm_campaign=share